abagovomab 41
abciximab 28
abituzumab 28
abrilumab 17
actoxumab 23
adalimumab 15
aducanumab 17
afasevikumab 13
alacizumab_pegol 9
alemtuzumab 30
alirocumab 18
amatuximab 46
andecaliximab 23
anifrolumab 25
anrukinzumab 18
aprutumab 17
aprutumab_ixadotin 17
arcitumomab 20
ascrinvacumab 11
atezolizumab 14
atinumab 17
avelumab 13
basiliximab 46
bavituximab 36
begelomab 36
benralizumab 29
bevacizumab_beta 22
bezlotoxumab 23
bimagrumab 18
bleselumab 22
blinatumomab 40
blosozumab 31
bococizumab 23
brazikumab 20
brentuximab_vedotin 32
briakinumab 21
brodalumab 20
brolucizumab 30
brontictuzumab 27
burosumab 24
cabiralizumab 31
camrelizumab 15
canakinumab 24
cantuzumab_ravtansin 39
carlumab 21
carotuximab 13
cergutuzumab_amunaleukin2 32
cergutuzumab_amunaleukin 32
certolizumab_pegol 27
cetiximab 42
citatuzumab_bogatox 31
cixutumumab 35
clivatuzumab_tetraxetan 23
codrituzumab 22
conatumumab 19
concizumab 21
crenezumab 19
crizanlizumab 29
crotedumab 21
dacetuzumab 22
daclizumab 17
dalotuzumab 27
dapirolizumab_pegol 26
daratumumab 15
dectrekumab 12
demcizumab 29
denosumab 8
depatuxizumab 23
depatuxizumab_mafodotin 23
dezamizumab 28
dinutuximab 38
diridavumab 23
domagrozumab 18
drozitumab 21
duligotuzumab 20
durvalumab 17
dusigitumab 26
efalizumab 37
efungumab 25
eldelumab 20
elezanumab 27
elgemtumab 10
elotuzumab 17
emactuzumab 23
emapalumab 28
emibetuzumab 24
enavatuzumab 26
enfortumab_vedotin 15
enoblituzumab 20
enokizumab 29
enoticumab 22
ensituximab 38
eptinezumab 15
erenumab 27
etaracizumab 17
etrolizumab 23
evinacumab 23
evolocumab 26
farletuzumab 3
fasinumab 23
fezakinumab 29
fibatuzumab 18
ficlatuzumab 29
firivumab 31
flanvotumab 27
fletikumab 33
foralumab 18
foravirumab 18
fremanezumab 32
fresolimumab 22
fulranumab 23
futuximab 24
galcanezumab 20
ganitumab 25
gantenerumab 16
gemetuzumab 30
gemtuzumab2 23
gemtuzumab 28
gevokizumab 25
girentuximab 28
glembatumumab 22
glembatumumab_vedotin 22
guselkumab 26
ibalizumab 34
ibritumomab 34
icrucumab 15
idarucizumab 28
ifabotuzumab 18
imalumab 15
imgatuzumab 25
inclacumab 25
indatuximab_ravtansin 29
indusatumab 21
inebilizumab 27
intetumumab 19
iodine_girentuximab 31
ipilimumab 5
iratumumab 12
isatuximab 36
itolizumab 27
ixekizumab 32
labetuzumab_govitecan 26
lambrolizumab 34
lampalizumab 28
lanadelumab 21
landogrozumab 18
laprituximab 36
lebrikizumab 31
lendalizumab 29
lenzilumab 25
lifastuzumab_vedotin 25
ligelizumab 27
lilotomab 37
lirilumab 24
lodelcizumab 19
lokivetmab 17
lorvotuzumab_mertansin 18
lucatumumab 31
lumretuzumab 28
lupartumab 20
lutikizumab 16
margetuximab 35
milatuzumab 31
mirvetuximab 40
mirvetuximab_soravtansin 40
modotuximab 45
mogamulizumab 22
monalizumab 28
motavizumab 31
moxetumomab_pasudotox 19
namilumab 24
naratuximab 35
naratuximab_emtansin 35
narnatumab 21
navicixizumab2 29
navicixizumab 31
navivumab 34
necitumumab 15
nemolizumab 31
nesvacumab 14
nivolumab 18
obiltoxaximab 22
obinutuzumab 33
ocaratuzumab 29
ofatumumab 17
olaratumab 27
olokizumab 24
omalizumab 19
onartuzumab 24
ontuxizumab 31
opicinumab 15
orticumab 12
otelixizumab 40
oxelumab 12
ozanezumab 28
pamrevlumab 13
panobacumab 19
parsatuzumab 32
pasotuxizumab 17
pateclizumab 19
patritumab 19
pembrolizumab 34
perakizumab 24
pidilizumab 16
pinatuzumab_vedotin 19
plozalizumab 23
pogalizumab 29
polatuzumab_vedotin 21
ponezumab 30
prezalumab 15
pritoxaximab 43
quilizumab 19
racotumomab 34
radretumab 18
ralpancizumab 27
ramucirumab 15
ranevetmab 29
ranibizumab 21
refanezumab 27
remtolumab 19
rilotumumab 21
rinucumab 20
risankizumab 36
rituximab 26
rivabazumab 25
robatumumab 22
roledumab 30
romosozumab 29
rontalizumab 23
rosmantuzumab 27
rozanolixizumab 22
sacituzumab 31
sacituzumab_govitecan 31
samalizumab 30
sapelizumab 23
sarilumab 18
secukinumab 20
seribantumab 19
setoxaximab 36
sifalimumab 16
siltuximab 22
simtuzumab 30
sirukumab 11
solanezumab 28
solitomab 28
stamulumab 24
suptavumab 28
suvizumab 18
tabalumab 24
tadocizumab 19
tamtuvetmab 30
tanezumab 25
tarextumab 12
tavolixizumab 12
telisotuzumab 36
teplizumab 19
tesidolumab 25
tezepelumab 27
tigatuzumab 16
tildrakizumab 28
timolumab 17
tisotumab 14
tosatoxumab 34
tositumomab 31
tralokinumab 39
trastuzumab 25
tregalizumab 22
trevogrumab 12
ublituximab 30
urelumab 16
ustekinumab 30
utomilumab 32
vadastuximab 33
vadastuximab_talirin 33
vandortuzumab_vedotin 23
vantictumab 28
vanucizumab2 22
vanucizumab 39
varlilumab 19
vatelizumab 26
vedolizumab 32
veltuzumab 15
vesencumab 13
vorsetuzumab 29
vorsetuzumab_mafodotin 29
vunakizumab 38
xentuzumab 20
zatuximab 45
